Drugs in drinking water treatment options

Fate of Pharmaceuticals in the Environment and in Water Treatment Systems

Volumn , Issue , 2007, Pages 217-228

  Weinberg, Howard S ^a   Pereira, Vanessa J ^b   Ye, Zhengqi ^c  

^a University of North Carolina at Chapel Hill   (United States)

^b INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^c Enthalpy Analytical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85016921174     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420052336     Document Type: Chapter

References (52)

1. Daughton, C.G. In Water: Science and Issues; Dasch, J., Ed.; Macmillan Reference USA: New York, 2003; Vol. 1, pp 158-164.
2. Snyder, S.A. et al. Occurrence of EDCs and pharmaceuticals in US drinking waters. Paper presented at the American Water Works Association Water Quality Technology Conference, Quebec City, November, 2005.
3. Ternes, T. In Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues; Daughton, C.G. and Jones-Lepp, T.L., Eds.; American Chemical Society: Washington, DC, 2001; pp 39-54.
4. Heberer, T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data, Toxicol. Lett. 2002, 131, 5-17.
5. Halling-Sørensen, B., Nors Nielson, S., Lanzky, P.F., Ingerslev, F., Holten Lutzhoft, H.C., and Jorgensen, S.E. Occurrence, fate and effects of pharmaceutical substances in the environment—a review, Chemosphere 1998, 36, 357-393.
6. Daughton, C.G. and Ternes, T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?, Environ. Health Persp. 1999, 107, 907-938.
7. Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B., and Buxton, H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance, Environ. Sci. Technol. 2002, 36, 1202-1211.
8. Putschew, A., Schittko, S., and Jekel, M. Quantification of triiodinated benzene derivatives and X-ray contrast media in water samples by liquid chromatography-electrospray tandem mass spectrometry, J. Chromatogr. A. 2001, 930, 127-134.
9. Ye, Z., Weinberg, H.S., and Meyer, M.T. Occurence of antibiotics in drinking water, 4th International Conference on Pharmaceuticals and Endocrine Disrupting Chemicals in Water, Minneapolis, MN, 2004.
10. Costanzo, S.D., Murby, J., and Bates, J. Ecosystem response to antibiotics entering the aquatic environment, Mar. Pollut. Bull. 2005, 51, 218-223.
11. Öllers, S., Singer, H.P., Fässler, P., and Müller, S.R. Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng/1 level in surface and waste water, J. Chromatogr. A. 2001, 911, 225-234.
12. Stackelberg, P.E., Furlong, E.T., Meyer, M.T., Zaugg, S.D., Henderson, A.K., and Reissman, D.B. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant, Sci. Total Environ. 2004, 329, 99-113.
13. Ternes, T.A. Occurrence of drugs in German sewage treatment plants and rivers, Water Res. 1998, 32, 3245-3260.
14. Snyder, S.A., Westerhoff, P., Yoon, Y., and Sedlak, D.L. Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry, Environ. Eng. Sci. 2003, 20(5), 449-469.
15. Adams, C., Wang, Y., Loftin, K., and Meyer, M. Removal of antibiotics from surface and distilled water in conventional water treatment processes, J. Environ. Eng. 2002, 128(3), 253-260.
16. Westerhoff, P., Yoon, Y., Snyder, S., and Wert, E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes, Environ. Sci. Technol. 2005, 39(17), 6649-6663.
17. Sacher, F., Haist-Gulde, B., Brauch, H.-J., Zullei-Seibert, N., Preuss, G., Meisenheimer, M., Welsch, H., and Ternes, T.A. Behavior of selected pharmaceuticals during drinking-water treatment, Book of Abstracts, 219th ACS National Meeting, San Francisco, CA, March 26-30, 2000, ENVR-045.
18. Kim, S.D., Cho, J., Kim, I.S., Vanderford, B.J., and Snyder, S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters, Water Res. 2007, 41(5), 1013-1021.
19. Yoon, Y., Westerhoff, P., Snyder, S.A., and Wert, E.C. Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products, J. Membrane Sci. 2006, 270(1-2), 88.
20. USEPA, Membrane Filtration Guidance Manual, U.S. Environmental Protection Agency, Cincinnati, OH, 2005.
21. Rice, R.G. and Gomez-Taylor, M. Occurrence of by-products of strong oxidants reacting with drinking water contaminants—Scope of the problem, Environ. Health Perspect. 1986, 69, 31-44.
22. Abia, L., Armesto, X.L., Canle, L.M., Garcia, M.V., and Santaballa, J.A. Oxidation of aliphatic amines by aqueous chlorine, Tetrahedron 1998, 54, 521-530.
23. Armesto, X.L., Canle, M.L., Garcia, M.V., and Santaballa, J.A. Aqueous chemistry of N-halo-compounds, Chem. Soc. Rev. 1998, 27, 453-460.
24. Dodd, M.C. Chemical oxidation of aquatic antibiotic microcontaminants by free and combined chlorine. MS thesis, Georgia Institute of Technology, 2003.
25. Dodd, M.C. and Huang, C.-H. Transformation of the antibacterial agent sulfamethoxazole in reactions with chlorine: kinetics, mechanisms, and pathways, Environ. Sci. Technol. 2004, 38, 5607-5615.
26. Dodd, M.C., Shah, A.D., Von Gunten, U., and Huang, C.-H. Interactions of fluoroquinolone antibacterial agents with aqueous chlorine: reaction kinetics, mechanisms, and transformation pathways, Environ. Sci. Technol. 2005, 39(18), 7065-7076.
27. Chamberlain, E. and Adams, C. Oxidation of sulfonamides, macrolides, and carbadox with free chlorine and monochloramine, Water Res. 2006, 40, 2517-2526.
28. Shah, A.D., Kim, J.-H., and Huang, C.-H. Reaction kinetics and transformation of carbadox and structurally related compounds with aqueous chlorine, Environ. Sci. Technol. in press.
29. Hoigné, J. and Bader, H. Kinetics of reactions of chlorine dioxide (OClO) in water-I Rate constants for inorganic and organic compounds, Water Res. 1994, 28, 45-55.
30. Huber, M.M., Korhonen, S., Ternes, T.A., and Von Gunten, U. Oxidation of pharmaceuticals during water treatment with chlorine dioxide, Water Res. 2005, 39, 3607-3617.
31. Sithole, B.B. and Guy, R.D. Models for oxytetracycline in aquatic environments. II. Interaction with humic substances, Water Air Soil Pollut. 1987, 32, 315-321.
32. Haas, C.N., Ed. Water Quality and Treatment; 4th edition; McGraw-Hill: New York, 1990.
33. von Gunten, U. Ozonation of drinking water: part I. oxidation kinetics and product formation, Water Res. 2003, 37, 1443-1467.
34. Zwiener, C. and Frimmel, F.H. Oxidative treatment of pharmaceuticals in water, Water Res. 2000, 34, 1881-1885.
35. Huber, M.M., Canonica, S., Park, G.-Y., and von Gunten, U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes, Environ. Sci. Technol. 2003, 37, 1016-1024.
36. McDowell, D.C., Huber, M.M., Wagner, M., von Gunten, U., and Ternes, T.A. Ozonation of carbamazepine in drinking water: identification and kinetic study of major oxidation products, Environ. Sci. Technol. 2005, 39(20), 8014-8022.
37. Hua, W., Bennett, E.R., and Letcher, R.J. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the Upper Detroit River, Ontario, Canada, Water Res. 2006, 40, 2259-2266.
38. Sharpless, C.M. and Linden, K.L. UV photolysis of nitrate: effects of natural organic matter and dissolved inorganic carbon and implications for UV water disinfection, Environ. Sci. Technol. 2001, 35, 2949-2955.
39. Schwarzenbach, R.P., Gschwend, P.M., and Imboden, D.M. Environmental Organic Chemistry; Wiley-Interscience: New York, 1993.
40. Sharpless, C.M. and Linden, K.L. Experimental and model comparisons of low-and medium-pressure Hg lamps for the direct and H2O2 assisted UV photodegradation of N-nitrosodimethylamine in simulated drinking water, Environ. Sci. Technol. 2003, 37, 1933-1940.
41. Rosenfeldt, E. and Linden, K.G. Degradation of endocrine disrupting chemicals bisphenol A, ethinyl estradiol, and estradiol during UV photolysis and advanced oxidation processes, Environ. Sci. Technol. 2004, 38(20), 5476-5483.
42. Vogna, D., Marotta, R., Andreozzi, R., Napolitano, A. and d’Ischia, M. Kinetic and chemical assessment of the UV/H2O2 treatment of antiepileptic drug carbamazepine, Chemosphere 2004, 54(4), 497-505.
43. Andreozzi, R., Caprio, V., Marotta, R., and Vogna, D. Paracetamol oxidation from aqueous solutions by means of ozonation and H2O2/UV system, Water Res. 2003, 37(5), 993-1004.
44. Vogna, D., Marotta, R., Napolitano, A., Andreozzi, R. and d’Ischia, M. Advanced oxidation of the pharmaceutical drug diclofenac with UV/H2O2 and ozone, Water Res. 2004, 38(2), 414-422.
45. Pereira, V.J., Weinberg, H.S., Linden, K.G., and Singer, P.C. UV degradation kinetics and modeling of pharmaceutical compounds in laboratory grade and surface water via direct and indirect photolysis at 254 nm, Environ. Sci. Technol. 2007, 41(5) 1682-1688.
46. Pereira, V.J., Linden, K.G., and Weinberg, H.S. Evaluation of UV irradiation for photolytic and oxidative degradation of pharmaceutical compounds in water. Water Res. (in press), available online June 2007.
47. Fujishima, A., Rao, T.N., and Tryk, D.A. Titanium dioxide photocatalysis, J. Photochem. Photobiol. C: Photochem. Rev. 2000, 1, 1-21.
48. Doll, T.E. and Frimmel, F.H. Photocatalytic degradation of carbamazepine, clofibric acid and iomeprol with P25 and Hombikat UV100 in the presence of natural organic matter (NOM) and other organic water constituents, Water Res. 2005, 39(2-3), 403-411.
49. Doll, T.E. and Frimmel, F.H. Cross-flow microfiltration with periodical back-washing for photocatalytic degradation of pharmaceutical and diagnostic residues-evaluation of the long-term stability of the photocatalytic activity of TiO2, Water Res. 2005, 39(5), 847-854.
50. Cleuvers, M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects, Toxicol. Lett. 2003, 142, 185-194.
51. Webb, S., Ternes, T., Gibert, M., and Olejniczak, K. Indirect human exposure to pharmaceuticals via drinking water, Toxicol. Lett. 2003, 142, 157-167.
52. Schwartz, T., Kohnen, W., Jansen, B., and Obst, U. Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms, FEMS Microbiol. Ecol. 2003, 43, 325-335.